Alberto Fernández-Tejada

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 11

Top Venues

Nature reviews. Chemistry

Chemical science

Chemical Society reviews

ACS chemical biology

Universidad de la Rioja Departamento de Química (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Universidad de la Rioja Departamento de Química Oct 01 2004 - Aug 31 2009

Spain

PHD :: Departamento de Química

Publications

Carlo Pifferi, Leire Aguinagalde, Ane Ruiz-de-Angulo, Nagore Sacristán, Priscila Tonon Baschirotto, Ana Poveda, Jiménez-Barbero Jesús, Juan Anguita, Alberto Fernández-Tejada
Development of synthetic, self-adjuvanting, and self-assembling anticancer vaccines based on a minimal saponin adjuvant and the tumor-associated MUC1 antigen. Chemical science 14 (13) (2023)
Carlo Pifferi, Roberto Fuentes, Alberto Fernández-Tejada
Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of action. Nature reviews. Chemistry 5 (3) (2021)
Carlo Pifferi, Roberto Fuentes, Alberto Fernández-Tejada
Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of action. Nature reviews. Chemistry 5 (3) (2021)
Roberto Fuentes, Leire Aguinagalde, Nagore Sacristán, Alberto Fernández-Tejada
Design, synthesis, and initial immunological evaluation of glycoconjugates based on saponin adjuvants and the Tn antigen. Chemical communications (Cambridge, England) 57 (86) (2021)
Abhijit Saha, Davide Bello, Alberto Fernández-Tejada
Advances in chemical probing of protein O-GlcNAc glycosylation: structural role and molecular mechanisms. Chemical Society reviews 50 (18) (2021)
Carlo Pifferi, Roberto Fuentes, Alberto Fernández-Tejada
Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of action. Nature reviews. Chemistry (2021)
Roberto Fuentes, Ane Ruiz-de-Angulo, Nagore Sacristán, Claudio Daniel Navo, Gonzalo Jiménez-Osés, Juan Anguita, Alberto Fernández-Tejada
Replacing the Rhamnose-Xylose Moiety of QS-21 with Simpler Terminal Disaccharide Units Attenuates Adjuvant Activity in Truncated Saponin Variants. Chemistry (Weinheim an der Bergstrasse, Germany) 27 (14) (2021)
Carlo Pifferi, Ane Ruiz-de-Angulo, David Goyard, Claire Tiertant, Nagore Sacristán, Diego Barriales, Nathalie Berthet, Juan Anguita, Olivier Renaudet, Alberto Fernández-Tejada
Chemical synthesis and immunological evaluation of new generation multivalent anticancer vaccines based on a Tn antigen analogue. Chemical science 11 (17) (2020)
Virgil Schijns, Alberto Fernández-Tejada, Žarko Barjaktarović, Ilias Bouzalas, Jens Brimnes, Sergey Chernysh, Sveinbjorn Gizurarson, İhsan GÜrsel, Žiga Jakopin, Maria Lawrenz, Cristina Nativi, Stephane Paul, Gabriel Kristian Pedersen, Camillo Rosano, Ane Ruiz-de-Angulo, Bram Slütter, Aneesh Thakur, Dennis Christensen, Ed C Lavelle
Modulation of immune responses using adjuvants to facilitate therapeutic vaccination. Immunological reviews 296 (1) (2020)
S Munir Alam, Baptiste Aussedat, Yusuf Vohra, R Ryan Meyerhoff, Evan M Cale, William E Walkowicz, Nathan A Radakovich, Kara Anasti, Lawrence Armand, Robert Parks, Laura L Sutherland, Richard Scearce, M Gordon Joyce, Marie Pancera, Aliaksandr Druz, Ivelin S Georgiev, Tarra A Von Holle, Amanda Eaton, Christopher Fox, Steven G Reed, Mark K Louder, Robert T Bailer, Lynn Morris, Salim S Abdool Karim, Myron S Cohen, Hua-Xin Liao, David C Montefiori, Peter K Park, Alberto Fernández-Tejada, Kevin Wiehe, Sampa Santra, Thomas B Kepler, Kevin O Saunders, Joseph G Sodroski, Peter D Kwong, John R Mascola, Mattia Bonsignori, M Anthony Moody, Samuel Danishefsky, Barton F Haynes
Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide. Science translational medicine 9 (381) (2017)
Thapi Dharma Rao, Alberto Fernández-Tejada, Abram Axelrod, Nestor Rosales, Xiujun Yan, Sahityasri Thapi, Amy Wang, Kay J Park, Brandon Nemieboka, Jingyi Xiang, Jason S Lewis, Narciso Olvera, Douglas A Levine, Samuel J Danishefsky, David R Spriggs
Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer Growth. ACS chemical biology 12 (8) (2017)

Alberto Fernández-Tejada.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Alberto Fernández-Tejada